Amnis (Biotechnology) Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Amnis (Biotechnology) General Information

Description

Manufacturer of cell analysis systems for the imaging and analysis of cells in flow. The company's ImageStreamX and FlowSight imaging flow cytometers combine the speed and sensitivity of flow cytometry with the power of digital microscopy serving a broad spectrum of Life Sciences research market needs.

Contact Information

Website
www.amnis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 645 Elliott Avenue West
  • Suite 100
  • Seattle, WA 98119
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 645 Elliott Avenue West
  • Suite 100
  • Seattle, WA 98119
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amnis (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 30-Aug-2011 Completed Generating Revenue
9. Later Stage VC 29-Jul-2009 Completed Generating Revenue
8. Later Stage VC 15-Dec-2007 Completed Generating Revenue
7. Later Stage VC (Series C) 27-Mar-2006 Completed Generating Revenue
6. Later Stage VC 14-Sep-2004 Completed Generating Revenue
5. Mezzanine 17-Mar-2003 Completed Generating Revenue
4. Early Stage VC (Series B) 03-Dec-2001 Completed Generating Revenue
3. Early Stage VC (Series A) 28-Mar-2000 Completed Product Development
2. Seed Round 01-Feb-1999 $100K $100K Completed Startup
1. University Spin-Out 01-Jan-1999 Completed Startup
To view Amnis (Biotechnology)’s complete valuation and funding history, request access »

Amnis (Biotechnology) Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alliance of Angels Angel Group Minority
Cayuga Venture Fund Venture Capital Minority
Crown Venture Fund Venture Capital Minority
Emerging Technology Partners (Venture Capital) Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 15 investors. Get the full list »

Amnis (Biotechnology) FAQs

  • When was Amnis (Biotechnology) founded?

    Amnis (Biotechnology) was founded in 1999.

  • Where is Amnis (Biotechnology) headquartered?

    Amnis (Biotechnology) is headquartered in Seattle, WA.

  • What industry is Amnis (Biotechnology) in?

    Amnis (Biotechnology)’s primary industry is Biotechnology.

  • Is Amnis (Biotechnology) a private or public company?

    Amnis (Biotechnology) is a Private company.

  • What is Amnis (Biotechnology)’s current revenue?

    The current revenue for Amnis (Biotechnology) is .

  • How much funding has Amnis (Biotechnology) raised over time?

    Amnis (Biotechnology) has raised $34.3M.

  • Who are Amnis (Biotechnology)’s investors?

    Alliance of Angels, Cayuga Venture Fund, Crown Venture Fund, Emerging Technology Partners (Venture Capital), and are 5 of 15 investors who have invested in Amnis (Biotechnology).

  • When was Amnis (Biotechnology) acquired?

    Amnis (Biotechnology) was acquired on 30-Aug-2011.

  • Who acquired Amnis (Biotechnology)?

    Amnis (Biotechnology) was acquired by Merck Millipore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process